Laurion Capital Management LP Novavax Inc Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $4.02 Million - $8.34 Million	-110,822 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $7.73 Million - $15.8 Million	110,822 New	110,822 $8.16 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $403,783 - $614,487	-2,271 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $274,791 - $585,168	2,271 New	2,271 $482,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $771,652 - $1.37 Million	-9,800 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $778,512 - $1.75 Million	9,800 New	9,800 $1.06 Million

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.